nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—ALB—acquired immunodeficiency syndrome	0.141	1	CbGaD
Amitriptyline—ORM1—Saquinavir—acquired immunodeficiency syndrome	0.0242	0.0418	CbGbCtD
Amitriptyline—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0161	0.0278	CbGbCtD
Amitriptyline—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0152	0.0262	CbGbCtD
Amitriptyline—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0152	0.0262	CbGbCtD
Amitriptyline—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0137	0.0237	CbGbCtD
Amitriptyline—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.012	0.0206	CbGbCtD
Amitriptyline—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0115	0.0198	CbGbCtD
Amitriptyline—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0108	0.0186	CbGbCtD
Amitriptyline—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0108	0.0186	CbGbCtD
Amitriptyline—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0105	0.0182	CbGbCtD
Amitriptyline—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0104	0.0179	CbGbCtD
Amitriptyline—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0104	0.0179	CbGbCtD
Amitriptyline—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0104	0.0179	CbGbCtD
Amitriptyline—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0103	0.0177	CbGbCtD
Amitriptyline—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0102	0.0176	CbGbCtD
Amitriptyline—ALB—Zidovudine—acquired immunodeficiency syndrome	0.00977	0.0169	CbGbCtD
Amitriptyline—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00964	0.0166	CbGbCtD
Amitriptyline—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.00946	0.0163	CbGbCtD
Amitriptyline—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00933	0.0161	CbGbCtD
Amitriptyline—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.00906	0.0156	CbGbCtD
Amitriptyline—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0089	0.0153	CbGbCtD
Amitriptyline—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0089	0.0153	CbGbCtD
Amitriptyline—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00872	0.015	CbGbCtD
Amitriptyline—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00872	0.015	CbGbCtD
Amitriptyline—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00853	0.0147	CbGbCtD
Amitriptyline—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00819	0.0141	CbGbCtD
Amitriptyline—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00819	0.0141	CbGbCtD
Amitriptyline—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.00805	0.0139	CbGbCtD
Amitriptyline—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00802	0.0138	CbGbCtD
Amitriptyline—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00802	0.0138	CbGbCtD
Amitriptyline—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00788	0.0136	CbGbCtD
Amitriptyline—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00788	0.0136	CbGbCtD
Amitriptyline—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0078	0.0134	CbGbCtD
Amitriptyline—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00778	0.0134	CbGbCtD
Amitriptyline—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00755	0.013	CbGbCtD
Amitriptyline—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00753	0.013	CbGbCtD
Amitriptyline—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00733	0.0126	CbGbCtD
Amitriptyline—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00733	0.0126	CbGbCtD
Amitriptyline—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00731	0.0126	CbGbCtD
Amitriptyline—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00725	0.0125	CbGbCtD
Amitriptyline—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00725	0.0125	CbGbCtD
Amitriptyline—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00703	0.0121	CbGbCtD
Amitriptyline—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00674	0.0116	CbGbCtD
Amitriptyline—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00663	0.0114	CbGbCtD
Amitriptyline—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00663	0.0114	CbGbCtD
Amitriptyline—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00661	0.0114	CbGbCtD
Amitriptyline—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00661	0.0114	CbGbCtD
Amitriptyline—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00634	0.0109	CbGbCtD
Amitriptyline—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00626	0.0108	CbGbCtD
Amitriptyline—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0061	0.0105	CbGbCtD
Amitriptyline—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00607	0.0105	CbGbCtD
Amitriptyline—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00607	0.0105	CbGbCtD
Amitriptyline—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0059	0.0102	CbGbCtD
Amitriptyline—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00572	0.00987	CbGbCtD
Amitriptyline—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00555	0.00958	CbGbCtD
Amitriptyline—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00549	0.00948	CbGbCtD
Amitriptyline—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00549	0.00948	CbGbCtD
Amitriptyline—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00533	0.0092	CbGbCtD
Amitriptyline—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00533	0.0092	CbGbCtD
Amitriptyline—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00527	0.00909	CbGbCtD
Amitriptyline—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00511	0.00882	CbGbCtD
Amitriptyline—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00502	0.00867	CbGbCtD
Amitriptyline—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00502	0.00867	CbGbCtD
Amitriptyline—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00496	0.00855	CbGbCtD
Amitriptyline—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00466	0.00804	CbGbCtD
Amitriptyline—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00466	0.00804	CbGbCtD
Amitriptyline—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00421	0.00727	CbGbCtD
Amitriptyline—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00421	0.00727	CbGbCtD
Amitriptyline—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00395	0.00682	CbGbCtD
Amitriptyline—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00364	0.00628	CbGbCtD
Amitriptyline—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00353	0.00609	CbGbCtD
Amitriptyline—NTRK2—nerve—acquired immunodeficiency syndrome	0.00325	0.0455	CbGeAlD
Amitriptyline—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00319	0.00551	CbGbCtD
Amitriptyline—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00319	0.00551	CbGbCtD
Amitriptyline—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00306	0.00528	CbGbCtD
Amitriptyline—KCNA1—nerve—acquired immunodeficiency syndrome	0.00188	0.0263	CbGeAlD
Amitriptyline—ORM1—saliva—acquired immunodeficiency syndrome	0.00178	0.0249	CbGeAlD
Amitriptyline—NTRK2—retina—acquired immunodeficiency syndrome	0.00135	0.0188	CbGeAlD
Amitriptyline—OPRM1—nerve—acquired immunodeficiency syndrome	0.00105	0.0147	CbGeAlD
Amitriptyline—HRH4—blood—acquired immunodeficiency syndrome	0.000963	0.0135	CbGeAlD
Amitriptyline—HRH4—bone marrow—acquired immunodeficiency syndrome	0.000932	0.013	CbGeAlD
Amitriptyline—NTRK2—bone marrow—acquired immunodeficiency syndrome	0.000871	0.0122	CbGeAlD
Amitriptyline—NTRK2—spinal cord—acquired immunodeficiency syndrome	0.000868	0.0121	CbGeAlD
Amitriptyline—NTRK2—lung—acquired immunodeficiency syndrome	0.000789	0.011	CbGeAlD
Amitriptyline—KCNA1—retina—acquired immunodeficiency syndrome	0.000779	0.0109	CbGeAlD
Amitriptyline—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00077	0.0108	CbGeAlD
Amitriptyline—HTR7—nerve—acquired immunodeficiency syndrome	0.000742	0.0104	CbGeAlD
Amitriptyline—NTRK2—nervous system—acquired immunodeficiency syndrome	0.000731	0.0102	CbGeAlD
Amitriptyline—NTRK2—central nervous system—acquired immunodeficiency syndrome	0.000704	0.00984	CbGeAlD
Amitriptyline—DRD2—nerve—acquired immunodeficiency syndrome	0.000701	0.00981	CbGeAlD
Amitriptyline—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.000661	0.00924	CbGeAlD
Amitriptyline—HTR7—endothelium—acquired immunodeficiency syndrome	0.000632	0.00883	CbGeAlD
Amitriptyline—KCNQ3—lung—acquired immunodeficiency syndrome	0.000598	0.00837	CbGeAlD
Amitriptyline—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.000587	0.00821	CbGeAlD
Amitriptyline—KCND2—spinal cord—acquired immunodeficiency syndrome	0.000573	0.00801	CbGeAlD
Amitriptyline—HTR7—blood plasma—acquired immunodeficiency syndrome	0.000561	0.00784	CbGeAlD
Amitriptyline—NTRK2—brain—acquired immunodeficiency syndrome	0.000559	0.00781	CbGeAlD
Amitriptyline—KCNQ3—nervous system—acquired immunodeficiency syndrome	0.000554	0.00775	CbGeAlD
Amitriptyline—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000548	0.00766	CbGeAlD
Amitriptyline—NTRK2—lymph node—acquired immunodeficiency syndrome	0.00054	0.00755	CbGeAlD
Amitriptyline—KCNQ3—central nervous system—acquired immunodeficiency syndrome	0.000533	0.00746	CbGeAlD
Amitriptyline—HRH2—skin of body—acquired immunodeficiency syndrome	0.00053	0.00742	CbGeAlD
Amitriptyline—KCNQ2—nervous system—acquired immunodeficiency syndrome	0.00051	0.00713	CbGeAlD
Amitriptyline—CHRM5—skin of body—acquired immunodeficiency syndrome	0.000507	0.00708	CbGeAlD
Amitriptyline—KCNA1—spinal cord—acquired immunodeficiency syndrome	0.000502	0.00702	CbGeAlD
Amitriptyline—KCNQ2—central nervous system—acquired immunodeficiency syndrome	0.000491	0.00686	CbGeAlD
Amitriptyline—KCND2—nervous system—acquired immunodeficiency syndrome	0.000483	0.00675	CbGeAlD
Amitriptyline—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000478	0.00668	CbGeAlD
Amitriptyline—KCND2—central nervous system—acquired immunodeficiency syndrome	0.000465	0.0065	CbGeAlD
Amitriptyline—HTR2A—nerve—acquired immunodeficiency syndrome	0.000463	0.00647	CbGeAlD
Amitriptyline—KCND3—lung—acquired immunodeficiency syndrome	0.000455	0.00636	CbGeAlD
Amitriptyline—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000447	0.00626	CbGeAlD
Amitriptyline—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000431	0.00603	CbGeAlD
Amitriptyline—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000429	0.006	CbGeAlD
Amitriptyline—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000425	0.00594	CbGeAlD
Amitriptyline—HRH2—digestive system—acquired immunodeficiency syndrome	0.000424	0.00593	CbGeAlD
Amitriptyline—KCNQ3—brain—acquired immunodeficiency syndrome	0.000423	0.00592	CbGeAlD
Amitriptyline—KCNA1—nervous system—acquired immunodeficiency syndrome	0.000423	0.00592	CbGeAlD
Amitriptyline—KCND3—nervous system—acquired immunodeficiency syndrome	0.000421	0.00589	CbGeAlD
Amitriptyline—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.000411	0.00575	CbGeAlD
Amitriptyline—KCNA1—central nervous system—acquired immunodeficiency syndrome	0.000407	0.0057	CbGeAlD
Amitriptyline—KCND3—central nervous system—acquired immunodeficiency syndrome	0.000405	0.00567	CbGeAlD
Amitriptyline—HRH2—blood—acquired immunodeficiency syndrome	0.000404	0.00565	CbGeAlD
Amitriptyline—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000402	0.00563	CbGeAlD
Amitriptyline—CHRM4—nervous system—acquired immunodeficiency syndrome	0.000401	0.00561	CbGeAlD
Amitriptyline—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000394	0.00551	CbGeAlD
Amitriptyline—KCNQ2—brain—acquired immunodeficiency syndrome	0.00039	0.00545	CbGeAlD
Amitriptyline—CHRM4—central nervous system—acquired immunodeficiency syndrome	0.000386	0.0054	CbGeAlD
Amitriptyline—DRD3—nervous system—acquired immunodeficiency syndrome	0.000373	0.00521	CbGeAlD
Amitriptyline—KCND2—brain—acquired immunodeficiency syndrome	0.000369	0.00516	CbGeAlD
Amitriptyline—DRD3—central nervous system—acquired immunodeficiency syndrome	0.000359	0.00502	CbGeAlD
Amitriptyline—HTR6—nervous system—acquired immunodeficiency syndrome	0.000359	0.00502	CbGeAlD
Amitriptyline—HRH2—lung—acquired immunodeficiency syndrome	0.000354	0.00495	CbGeAlD
Amitriptyline—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.00035	0.00489	CbGeAlD
Amitriptyline—OPRD1—nervous system—acquired immunodeficiency syndrome	0.000347	0.00485	CbGeAlD
Amitriptyline—HTR6—central nervous system—acquired immunodeficiency syndrome	0.000345	0.00483	CbGeAlD
Amitriptyline—OPRD1—central nervous system—acquired immunodeficiency syndrome	0.000334	0.00467	CbGeAlD
Amitriptyline—OPRK1—nervous system—acquired immunodeficiency syndrome	0.000332	0.00465	CbGeAlD
Amitriptyline—HRH2—nervous system—acquired immunodeficiency syndrome	0.000328	0.00459	CbGeAlD
Amitriptyline—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000324	0.00453	CbGeAlD
Amitriptyline—KCNA1—brain—acquired immunodeficiency syndrome	0.000323	0.00452	CbGeAlD
Amitriptyline—KCND3—brain—acquired immunodeficiency syndrome	0.000322	0.0045	CbGeAlD
Amitriptyline—OPRK1—central nervous system—acquired immunodeficiency syndrome	0.00032	0.00447	CbGeAlD
Amitriptyline—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000319	0.00446	CbGeAlD
Amitriptyline—HRH2—central nervous system—acquired immunodeficiency syndrome	0.000316	0.00442	CbGeAlD
Amitriptyline—CHRM5—nervous system—acquired immunodeficiency syndrome	0.000313	0.00438	CbGeAlD
Amitriptyline—KCND3—lymph node—acquired immunodeficiency syndrome	0.000311	0.00435	CbGeAlD
Amitriptyline—CHRM4—brain—acquired immunodeficiency syndrome	0.000307	0.00429	CbGeAlD
Amitriptyline—CHRM5—central nervous system—acquired immunodeficiency syndrome	0.000302	0.00422	CbGeAlD
Amitriptyline—OPRM1—blood—acquired immunodeficiency syndrome	0.000291	0.00407	CbGeAlD
Amitriptyline—DRD2—retina—acquired immunodeficiency syndrome	0.00029	0.00406	CbGeAlD
Amitriptyline—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000286	0.004	CbGeAlD
Amitriptyline—DRD3—brain—acquired immunodeficiency syndrome	0.000285	0.00398	CbGeAlD
Amitriptyline—ORM1—blood—acquired immunodeficiency syndrome	0.000284	0.00397	CbGeAlD
Amitriptyline—OPRM1—spinal cord—acquired immunodeficiency syndrome	0.000281	0.00392	CbGeAlD
Amitriptyline—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.00028	0.00392	CbGeAlD
Amitriptyline—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000276	0.00386	CbGeAlD
Amitriptyline—ORM1—bone marrow—acquired immunodeficiency syndrome	0.000275	0.00385	CbGeAlD
Amitriptyline—HTR6—brain—acquired immunodeficiency syndrome	0.000274	0.00384	CbGeAlD
Amitriptyline—ORM1—spinal cord—acquired immunodeficiency syndrome	0.000274	0.00383	CbGeAlD
Amitriptyline—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.00027	0.00377	CbGeAlD
Amitriptyline—OPRD1—brain—acquired immunodeficiency syndrome	0.000265	0.0037	CbGeAlD
Amitriptyline—HTR1B—spinal cord—acquired immunodeficiency syndrome	0.000257	0.00359	CbGeAlD
Amitriptyline—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000254	0.00355	CbGeAlD
Amitriptyline—OPRK1—brain—acquired immunodeficiency syndrome	0.000254	0.00355	CbGeAlD
Amitriptyline—HRH2—brain—acquired immunodeficiency syndrome	0.000251	0.00351	CbGeAlD
Amitriptyline—ORM1—lung—acquired immunodeficiency syndrome	0.000249	0.00348	CbGeAlD
Amitriptyline—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000246	0.00344	CbGeAlD
Amitriptyline—HRH2—lymph node—acquired immunodeficiency syndrome	0.000242	0.00339	CbGeAlD
Amitriptyline—SLC6A4—blood—acquired immunodeficiency syndrome	0.000242	0.00339	CbGeAlD
Amitriptyline—SIGMAR1—blood—acquired immunodeficiency syndrome	0.00024	0.00336	CbGeAlD
Amitriptyline—CHRM5—brain—acquired immunodeficiency syndrome	0.00024	0.00335	CbGeAlD
Amitriptyline—OPRM1—nervous system—acquired immunodeficiency syndrome	0.000236	0.00331	CbGeAlD
Amitriptyline—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000233	0.00326	CbGeAlD
Amitriptyline—SIGMAR1—bone marrow—acquired immunodeficiency syndrome	0.000233	0.00325	CbGeAlD
Amitriptyline—SIGMAR1—spinal cord—acquired immunodeficiency syndrome	0.000232	0.00324	CbGeAlD
Amitriptyline—ORM1—nervous system—acquired immunodeficiency syndrome	0.000231	0.00323	CbGeAlD
Amitriptyline—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000229	0.00321	CbGeAlD
Amitriptyline—OPRM1—central nervous system—acquired immunodeficiency syndrome	0.000228	0.00318	CbGeAlD
Amitriptyline—CHRM3—digestive system—acquired immunodeficiency syndrome	0.000227	0.00317	CbGeAlD
Amitriptyline—SIGMAR1—vagina—acquired immunodeficiency syndrome	0.000223	0.00312	CbGeAlD
Amitriptyline—ORM1—central nervous system—acquired immunodeficiency syndrome	0.000222	0.00311	CbGeAlD
Amitriptyline—ADRA1B—brain—acquired immunodeficiency syndrome	0.000219	0.00306	CbGeAlD
Amitriptyline—HTR1B—nervous system—acquired immunodeficiency syndrome	0.000216	0.00302	CbGeAlD
Amitriptyline—HTR7—digestive system—acquired immunodeficiency syndrome	0.000216	0.00302	CbGeAlD
Amitriptyline—CHRM2—nervous system—acquired immunodeficiency syndrome	0.000215	0.00301	CbGeAlD
Amitriptyline—ADRA1D—brain—acquired immunodeficiency syndrome	0.000214	0.00299	CbGeAlD
Amitriptyline—SLC6A4—lung—acquired immunodeficiency syndrome	0.000212	0.00297	CbGeAlD
Amitriptyline—CHRM1—lung—acquired immunodeficiency syndrome	0.000211	0.00296	CbGeAlD
Amitriptyline—SIGMAR1—lung—acquired immunodeficiency syndrome	0.000211	0.00295	CbGeAlD
Amitriptyline—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000211	0.00295	CbGeAlD
Amitriptyline—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000211	0.00295	CbGeAlD
Amitriptyline—HTR1D—nervous system—acquired immunodeficiency syndrome	0.000209	0.00293	CbGeAlD
Amitriptyline—HTR1B—central nervous system—acquired immunodeficiency syndrome	0.000208	0.00291	CbGeAlD
Amitriptyline—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000207	0.0029	CbGeAlD
Amitriptyline—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000207	0.0029	CbGeAlD
Amitriptyline—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.000207	0.0029	CbGeAlD
Amitriptyline—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000206	0.00288	CbGeAlD
Amitriptyline—HTR7—blood—acquired immunodeficiency syndrome	0.000205	0.00287	CbGeAlD
Amitriptyline—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.000202	0.00282	CbGeAlD
Amitriptyline—CYP2C19—blood—acquired immunodeficiency syndrome	0.000201	0.00281	CbGeAlD
Amitriptyline—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.0002	0.00279	CbGeAlD
Amitriptyline—ADRA1A—blood—acquired immunodeficiency syndrome	0.000198	0.00277	CbGeAlD
Amitriptyline—HTR7—spinal cord—acquired immunodeficiency syndrome	0.000198	0.00277	CbGeAlD
Amitriptyline—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000197	0.00275	CbGeAlD
Amitriptyline—CHRM1—nervous system—acquired immunodeficiency syndrome	0.000196	0.00274	CbGeAlD
Amitriptyline—HTR2A—retina—acquired immunodeficiency syndrome	0.000192	0.00268	CbGeAlD
Amitriptyline—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000189	0.00265	CbGeAlD
Amitriptyline—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.000189	0.00264	CbGeAlD
Amitriptyline—SLC6A2—lung—acquired immunodeficiency syndrome	0.000187	0.00261	CbGeAlD
Amitriptyline—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000186	0.0026	CbGeAlD
Amitriptyline—OPRM1—brain—acquired immunodeficiency syndrome	0.000181	0.00253	CbGeAlD
Amitriptyline—HTR7—lung—acquired immunodeficiency syndrome	0.00018	0.00252	CbGeAlD
Amitriptyline—CHRM3—nervous system—acquired immunodeficiency syndrome	0.000175	0.00245	CbGeAlD
Amitriptyline—CYP2C8—blood—acquired immunodeficiency syndrome	0.000175	0.00245	CbGeAlD
Amitriptyline—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000175	0.00244	CbGeAlD
Amitriptyline—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000173	0.00242	CbGeAlD
Amitriptyline—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000172	0.00241	CbGeAlD
Amitriptyline—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.00118	CcSEcCtD
Amitriptyline—ORM1—lymph node—acquired immunodeficiency syndrome	0.00017	0.00238	CbGeAlD
Amitriptyline—DRD2—lung—acquired immunodeficiency syndrome	0.00017	0.00238	CbGeAlD
Amitriptyline—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.00117	CcSEcCtD
Amitriptyline—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00017	0.00117	CcSEcCtD
Amitriptyline—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.00117	CcSEcCtD
Amitriptyline—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.00017	0.00117	CcSEcCtD
Amitriptyline—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.00117	CcSEcCtD
Amitriptyline—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.00116	CcSEcCtD
Amitriptyline—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.000169	0.00236	CbGeAlD
Amitriptyline—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000169	0.00116	CcSEcCtD
Amitriptyline—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000168	0.00235	CbGeAlD
Amitriptyline—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.00115	CcSEcCtD
Amitriptyline—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.00115	CcSEcCtD
Amitriptyline—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000167	0.00233	CbGeAlD
Amitriptyline—HTR7—nervous system—acquired immunodeficiency syndrome	0.000167	0.00233	CbGeAlD
Amitriptyline—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000167	0.00233	CbGeAlD
Amitriptyline—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000166	0.00115	CcSEcCtD
Amitriptyline—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000166	0.00232	CbGeAlD
Amitriptyline—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000166	0.00114	CcSEcCtD
Amitriptyline—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.00114	CcSEcCtD
Amitriptyline—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000165	0.00114	CcSEcCtD
Amitriptyline—HTR1B—brain—acquired immunodeficiency syndrome	0.000165	0.00231	CbGeAlD
Amitriptyline—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.00114	CcSEcCtD
Amitriptyline—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000165	0.00231	CbGeAlD
Amitriptyline—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.00113	CcSEcCtD
Amitriptyline—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.00113	CcSEcCtD
Amitriptyline—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.00113	CcSEcCtD
Amitriptyline—CHRM2—brain—acquired immunodeficiency syndrome	0.000164	0.0023	CbGeAlD
Amitriptyline—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000164	0.00113	CcSEcCtD
Amitriptyline—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000164	0.00113	CcSEcCtD
Amitriptyline—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.00113	CcSEcCtD
Amitriptyline—CYP1A2—blood—acquired immunodeficiency syndrome	0.000164	0.00229	CbGeAlD
Amitriptyline—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000164	0.00113	CcSEcCtD
Amitriptyline—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000164	0.00113	CcSEcCtD
Amitriptyline—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.00113	CcSEcCtD
Amitriptyline—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000163	0.00228	CbGeAlD
Amitriptyline—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.00112	CcSEcCtD
Amitriptyline—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.00112	CcSEcCtD
Amitriptyline—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000163	0.00112	CcSEcCtD
Amitriptyline—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000162	0.00227	CbGeAlD
Amitriptyline—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.00112	CcSEcCtD
Amitriptyline—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000161	0.00111	CcSEcCtD
Amitriptyline—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000161	0.00111	CcSEcCtD
Amitriptyline—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.00111	CcSEcCtD
Amitriptyline—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.00111	CcSEcCtD
Amitriptyline—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000161	0.00111	CcSEcCtD
Amitriptyline—HRH1—digestive system—acquired immunodeficiency syndrome	0.000161	0.00225	CbGeAlD
Amitriptyline—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.00111	CcSEcCtD
Amitriptyline—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000161	0.00225	CbGeAlD
Amitriptyline—HTR7—central nervous system—acquired immunodeficiency syndrome	0.000161	0.00225	CbGeAlD
Amitriptyline—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.0011	CcSEcCtD
Amitriptyline—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.0011	CcSEcCtD
Amitriptyline—HTR1D—brain—acquired immunodeficiency syndrome	0.00016	0.00224	CbGeAlD
Amitriptyline—Rash—Didanosine—acquired immunodeficiency syndrome	0.00016	0.0011	CcSEcCtD
Amitriptyline—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00016	0.0011	CcSEcCtD
Amitriptyline—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00016	0.0011	CcSEcCtD
Amitriptyline—Headache—Didanosine—acquired immunodeficiency syndrome	0.000159	0.00109	CcSEcCtD
Amitriptyline—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000159	0.00109	CcSEcCtD
Amitriptyline—HTR2C—brain—acquired immunodeficiency syndrome	0.000159	0.00222	CbGeAlD
Amitriptyline—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.00109	CcSEcCtD
Amitriptyline—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.00109	CcSEcCtD
Amitriptyline—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000158	0.00109	CcSEcCtD
Amitriptyline—CYP3A5—blood—acquired immunodeficiency syndrome	0.000158	0.00221	CbGeAlD
Amitriptyline—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000158	0.00109	CcSEcCtD
Amitriptyline—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.00109	CcSEcCtD
Amitriptyline—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000158	0.00109	CcSEcCtD
Amitriptyline—DRD2—nervous system—acquired immunodeficiency syndrome	0.000158	0.00221	CbGeAlD
Amitriptyline—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.00108	CcSEcCtD
Amitriptyline—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.00108	CcSEcCtD
Amitriptyline—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.00108	CcSEcCtD
Amitriptyline—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.00108	CcSEcCtD
Amitriptyline—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000157	0.00108	CcSEcCtD
Amitriptyline—CYP2B6—blood—acquired immunodeficiency syndrome	0.000157	0.0022	CbGeAlD
Amitriptyline—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.00108	CcSEcCtD
Amitriptyline—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000157	0.00108	CcSEcCtD
Amitriptyline—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000157	0.00219	CbGeAlD
Amitriptyline—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000156	0.00108	CcSEcCtD
Amitriptyline—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000156	0.00107	CcSEcCtD
Amitriptyline—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000156	0.00107	CcSEcCtD
Amitriptyline—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000156	0.00107	CcSEcCtD
Amitriptyline—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.00107	CcSEcCtD
Amitriptyline—CYP2C9—blood—acquired immunodeficiency syndrome	0.000156	0.00218	CbGeAlD
Amitriptyline—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.00107	CcSEcCtD
Amitriptyline—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000155	0.00217	CbGeAlD
Amitriptyline—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000155	0.00107	CcSEcCtD
Amitriptyline—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.00107	CcSEcCtD
Amitriptyline—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000155	0.00216	CbGeAlD
Amitriptyline—ALB—brain—acquired immunodeficiency syndrome	0.000155	0.00216	CbGeAlD
Amitriptyline—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.00106	CcSEcCtD
Amitriptyline—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000154	0.00106	CcSEcCtD
Amitriptyline—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000154	0.00106	CcSEcCtD
Amitriptyline—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.00106	CcSEcCtD
Amitriptyline—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.00106	CcSEcCtD
Amitriptyline—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000152	0.00105	CcSEcCtD
Amitriptyline—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.00105	CcSEcCtD
Amitriptyline—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000152	0.00105	CcSEcCtD
Amitriptyline—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.00105	CcSEcCtD
Amitriptyline—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.00105	CcSEcCtD
Amitriptyline—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000152	0.00212	CbGeAlD
Amitriptyline—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.00104	CcSEcCtD
Amitriptyline—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000151	0.00104	CcSEcCtD
Amitriptyline—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000151	0.00104	CcSEcCtD
Amitriptyline—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.00104	CcSEcCtD
Amitriptyline—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.00104	CcSEcCtD
Amitriptyline—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000151	0.00104	CcSEcCtD
Amitriptyline—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000151	0.00104	CcSEcCtD
Amitriptyline—ADRA2A—blood—acquired immunodeficiency syndrome	0.000151	0.00211	CbGeAlD
Amitriptyline—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00015	0.00104	CcSEcCtD
Amitriptyline—SLC6A4—brain—acquired immunodeficiency syndrome	0.00015	0.0021	CbGeAlD
Amitriptyline—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00103	CcSEcCtD
Amitriptyline—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.00103	CcSEcCtD
Amitriptyline—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00103	CcSEcCtD
Amitriptyline—CHRM1—brain—acquired immunodeficiency syndrome	0.00015	0.00209	CbGeAlD
Amitriptyline—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.00103	CcSEcCtD
Amitriptyline—ALB—lymph node—acquired immunodeficiency syndrome	0.000149	0.00209	CbGeAlD
Amitriptyline—SIGMAR1—brain—acquired immunodeficiency syndrome	0.000149	0.00209	CbGeAlD
Amitriptyline—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.00103	CcSEcCtD
Amitriptyline—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.00102	CcSEcCtD
Amitriptyline—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000148	0.00102	CcSEcCtD
Amitriptyline—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.00102	CcSEcCtD
Amitriptyline—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.00102	CcSEcCtD
Amitriptyline—CYP2E1—blood—acquired immunodeficiency syndrome	0.000147	0.00206	CbGeAlD
Amitriptyline—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.00101	CcSEcCtD
Amitriptyline—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000147	0.00101	CcSEcCtD
Amitriptyline—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000147	0.00205	CbGeAlD
Amitriptyline—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.00101	CcSEcCtD
Amitriptyline—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.00101	CcSEcCtD
Amitriptyline—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.00101	CcSEcCtD
Amitriptyline—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000146	0.00101	CcSEcCtD
Amitriptyline—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.001	CcSEcCtD
Amitriptyline—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000146	0.001	CcSEcCtD
Amitriptyline—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000146	0.00204	CbGeAlD
Amitriptyline—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.001	CcSEcCtD
Amitriptyline—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.001	CcSEcCtD
Amitriptyline—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000145	0.00203	CbGeAlD
Amitriptyline—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000999	CcSEcCtD
Amitriptyline—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000145	0.000998	CcSEcCtD
Amitriptyline—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000998	CcSEcCtD
Amitriptyline—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000995	CcSEcCtD
Amitriptyline—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000994	CcSEcCtD
Amitriptyline—SIGMAR1—lymph node—acquired immunodeficiency syndrome	0.000144	0.00202	CbGeAlD
Amitriptyline—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.00099	CcSEcCtD
Amitriptyline—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000144	0.00099	CcSEcCtD
Amitriptyline—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000144	0.00099	CcSEcCtD
Amitriptyline—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000144	0.000989	CcSEcCtD
Amitriptyline—CYP1A2—lung—acquired immunodeficiency syndrome	0.000144	0.00201	CbGeAlD
Amitriptyline—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000144	0.000988	CcSEcCtD
Amitriptyline—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000986	CcSEcCtD
Amitriptyline—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.000985	CcSEcCtD
Amitriptyline—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000143	0.000984	CcSEcCtD
Amitriptyline—HRH1—vagina—acquired immunodeficiency syndrome	0.000142	0.00199	CbGeAlD
Amitriptyline—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000978	CcSEcCtD
Amitriptyline—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000142	0.00199	CbGeAlD
Amitriptyline—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000977	CcSEcCtD
Amitriptyline—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000975	CcSEcCtD
Amitriptyline—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000141	0.000974	CcSEcCtD
Amitriptyline—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.00097	CcSEcCtD
Amitriptyline—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.00097	CcSEcCtD
Amitriptyline—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000141	0.000969	CcSEcCtD
Amitriptyline—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000141	0.000967	CcSEcCtD
Amitriptyline—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000965	CcSEcCtD
Amitriptyline—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00014	0.000964	CcSEcCtD
Amitriptyline—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000963	CcSEcCtD
Amitriptyline—ADRA2A—vagina—acquired immunodeficiency syndrome	0.00014	0.00195	CbGeAlD
Amitriptyline—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.00096	CcSEcCtD
Amitriptyline—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000139	0.000959	CcSEcCtD
Amitriptyline—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000139	0.000958	CcSEcCtD
Amitriptyline—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000957	CcSEcCtD
Amitriptyline—Rash—Stavudine—acquired immunodeficiency syndrome	0.000139	0.000956	CcSEcCtD
Amitriptyline—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000955	CcSEcCtD
Amitriptyline—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000139	0.000955	CcSEcCtD
Amitriptyline—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.000954	CcSEcCtD
Amitriptyline—CYP3A5—lung—acquired immunodeficiency syndrome	0.000139	0.00194	CbGeAlD
Amitriptyline—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000953	CcSEcCtD
Amitriptyline—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.000953	CcSEcCtD
Amitriptyline—Headache—Stavudine—acquired immunodeficiency syndrome	0.000138	0.00095	CcSEcCtD
Amitriptyline—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000138	0.00095	CcSEcCtD
Amitriptyline—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000949	CcSEcCtD
Amitriptyline—CYP2B6—lung—acquired immunodeficiency syndrome	0.000138	0.00193	CbGeAlD
Amitriptyline—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000947	CcSEcCtD
Amitriptyline—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000137	0.000945	CcSEcCtD
Amitriptyline—Rash—Abacavir—acquired immunodeficiency syndrome	0.000137	0.000942	CcSEcCtD
Amitriptyline—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000137	0.000941	CcSEcCtD
Amitriptyline—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000941	CcSEcCtD
Amitriptyline—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.00094	CcSEcCtD
Amitriptyline—Headache—Abacavir—acquired immunodeficiency syndrome	0.000136	0.000936	CcSEcCtD
Amitriptyline—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000136	0.000933	CcSEcCtD
Amitriptyline—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000135	0.000932	CcSEcCtD
Amitriptyline—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000927	CcSEcCtD
Amitriptyline—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000135	0.00188	CbGeAlD
Amitriptyline—HRH1—lung—acquired immunodeficiency syndrome	0.000134	0.00188	CbGeAlD
Amitriptyline—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000926	CcSEcCtD
Amitriptyline—CHRM3—brain—acquired immunodeficiency syndrome	0.000134	0.00187	CbGeAlD
Amitriptyline—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000921	CcSEcCtD
Amitriptyline—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000921	CcSEcCtD
Amitriptyline—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.00092	CcSEcCtD
Amitriptyline—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.00092	CcSEcCtD
Amitriptyline—HTR1A—brain—acquired immunodeficiency syndrome	0.000133	0.00187	CbGeAlD
Amitriptyline—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.000915	CcSEcCtD
Amitriptyline—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.000913	CcSEcCtD
Amitriptyline—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000911	CcSEcCtD
Amitriptyline—SLC6A2—brain—acquired immunodeficiency syndrome	0.000132	0.00185	CbGeAlD
Amitriptyline—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000909	CcSEcCtD
Amitriptyline—ADRA2A—lung—acquired immunodeficiency syndrome	0.000132	0.00185	CbGeAlD
Amitriptyline—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000131	0.000903	CcSEcCtD
Amitriptyline—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000902	CcSEcCtD
Amitriptyline—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000131	0.000902	CcSEcCtD
Amitriptyline—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000131	0.000901	CcSEcCtD
Amitriptyline—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000897	CcSEcCtD
Amitriptyline—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000892	CcSEcCtD
Amitriptyline—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000891	CcSEcCtD
Amitriptyline—CYP2E1—lung—acquired immunodeficiency syndrome	0.000129	0.00181	CbGeAlD
Amitriptyline—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000129	0.000887	CcSEcCtD
Amitriptyline—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000885	CcSEcCtD
Amitriptyline—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000883	CcSEcCtD
Amitriptyline—HTR2A—blood—acquired immunodeficiency syndrome	0.000128	0.00179	CbGeAlD
Amitriptyline—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.00088	CcSEcCtD
Amitriptyline—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000128	0.00179	CbGeAlD
Amitriptyline—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000128	0.000879	CcSEcCtD
Amitriptyline—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000879	CcSEcCtD
Amitriptyline—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000128	0.00178	CbGeAlD
Amitriptyline—HTR7—brain—acquired immunodeficiency syndrome	0.000128	0.00178	CbGeAlD
Amitriptyline—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000877	CcSEcCtD
Amitriptyline—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000876	CcSEcCtD
Amitriptyline—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000876	CcSEcCtD
Amitriptyline—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.000871	CcSEcCtD
Amitriptyline—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000868	CcSEcCtD
Amitriptyline—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000126	0.000867	CcSEcCtD
Amitriptyline—ABCB1—retina—acquired immunodeficiency syndrome	0.000126	0.00176	CbGeAlD
Amitriptyline—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000857	CcSEcCtD
Amitriptyline—HRH1—nervous system—acquired immunodeficiency syndrome	0.000125	0.00174	CbGeAlD
Amitriptyline—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000125	0.00174	CbGeAlD
Amitriptyline—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000851	CcSEcCtD
Amitriptyline—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.00085	CcSEcCtD
Amitriptyline—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000123	0.00173	CbGeAlD
Amitriptyline—ADRA1A—brain—acquired immunodeficiency syndrome	0.000123	0.00172	CbGeAlD
Amitriptyline—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000123	0.00172	CbGeAlD
Amitriptyline—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000845	CcSEcCtD
Amitriptyline—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000844	CcSEcCtD
Amitriptyline—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000123	0.00171	CbGeAlD
Amitriptyline—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000843	CcSEcCtD
Amitriptyline—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000122	0.00171	CbGeAlD
Amitriptyline—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000122	0.000839	CcSEcCtD
Amitriptyline—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000122	0.000838	CcSEcCtD
Amitriptyline—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000836	CcSEcCtD
Amitriptyline—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000121	0.000831	CcSEcCtD
Amitriptyline—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000831	CcSEcCtD
Amitriptyline—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000121	0.00083	CcSEcCtD
Amitriptyline—DRD2—brain—acquired immunodeficiency syndrome	0.000121	0.00169	CbGeAlD
Amitriptyline—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000828	CcSEcCtD
Amitriptyline—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.000826	CcSEcCtD
Amitriptyline—HRH1—central nervous system—acquired immunodeficiency syndrome	0.00012	0.00168	CbGeAlD
Amitriptyline—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.00012	0.00167	CbGeAlD
Amitriptyline—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.000819	CcSEcCtD
Amitriptyline—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000818	CcSEcCtD
Amitriptyline—HTR2A—vagina—acquired immunodeficiency syndrome	0.000119	0.00166	CbGeAlD
Amitriptyline—CYP3A4—blood—acquired immunodeficiency syndrome	0.000119	0.00166	CbGeAlD
Amitriptyline—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000814	CcSEcCtD
Amitriptyline—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000813	CcSEcCtD
Amitriptyline—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000811	CcSEcCtD
Amitriptyline—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000118	0.00165	CbGeAlD
Amitriptyline—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000118	0.00081	CcSEcCtD
Amitriptyline—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.00081	CcSEcCtD
Amitriptyline—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000804	CcSEcCtD
Amitriptyline—CYP2D6—blood—acquired immunodeficiency syndrome	0.000117	0.00163	CbGeAlD
Amitriptyline—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000795	CcSEcCtD
Amitriptyline—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000115	0.00161	CbGeAlD
Amitriptyline—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000792	CcSEcCtD
Amitriptyline—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000784	CcSEcCtD
Amitriptyline—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000783	CcSEcCtD
Amitriptyline—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000114	0.000783	CcSEcCtD
Amitriptyline—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.00078	CcSEcCtD
Amitriptyline—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000113	0.000779	CcSEcCtD
Amitriptyline—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000775	CcSEcCtD
Amitriptyline—HTR2A—lung—acquired immunodeficiency syndrome	0.000112	0.00157	CbGeAlD
Amitriptyline—Rash—Indinavir—acquired immunodeficiency syndrome	0.000112	0.000773	CcSEcCtD
Amitriptyline—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000112	0.000772	CcSEcCtD
Amitriptyline—Headache—Indinavir—acquired immunodeficiency syndrome	0.000112	0.000768	CcSEcCtD
Amitriptyline—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000766	CcSEcCtD
Amitriptyline—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000758	CcSEcCtD
Amitriptyline—CYP2C8—brain—acquired immunodeficiency syndrome	0.000109	0.00152	CbGeAlD
Amitriptyline—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000747	CcSEcCtD
Amitriptyline—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000744	CcSEcCtD
Amitriptyline—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000736	CcSEcCtD
Amitriptyline—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000735	CcSEcCtD
Amitriptyline—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000733	CcSEcCtD
Amitriptyline—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.00073	CcSEcCtD
Amitriptyline—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000729	CcSEcCtD
Amitriptyline—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000106	0.000728	CcSEcCtD
Amitriptyline—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000725	CcSEcCtD
Amitriptyline—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000725	CcSEcCtD
Amitriptyline—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000104	0.00145	CbGeAlD
Amitriptyline—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000707	CcSEcCtD
Amitriptyline—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000704	CcSEcCtD
Amitriptyline—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000701	CcSEcCtD
Amitriptyline—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000699	CcSEcCtD
Amitriptyline—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000698	CcSEcCtD
Amitriptyline—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000698	CcSEcCtD
Amitriptyline—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000694	CcSEcCtD
Amitriptyline—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.0001	0.0014	CbGeAlD
Amitriptyline—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.99e-05	0.000688	CcSEcCtD
Amitriptyline—Dizziness—Ritonavir—acquired immunodeficiency syndrome	9.84e-05	0.000677	CcSEcCtD
Amitriptyline—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.81e-05	0.000675	CcSEcCtD
Amitriptyline—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	9.8e-05	0.000675	CcSEcCtD
Amitriptyline—CYP2B6—brain—acquired immunodeficiency syndrome	9.75e-05	0.00136	CbGeAlD
Amitriptyline—Pruritus—Lamivudine—acquired immunodeficiency syndrome	9.67e-05	0.000666	CcSEcCtD
Amitriptyline—CYP3A4—nervous system—acquired immunodeficiency syndrome	9.63e-05	0.00135	CbGeAlD
Amitriptyline—Nausea—Delavirdine—acquired immunodeficiency syndrome	9.56e-05	0.000658	CcSEcCtD
Amitriptyline—HRH1—brain—acquired immunodeficiency syndrome	9.52e-05	0.00133	CbGeAlD
Amitriptyline—CYP2D6—nervous system—acquired immunodeficiency syndrome	9.48e-05	0.00133	CbGeAlD
Amitriptyline—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.48e-05	0.000652	CcSEcCtD
Amitriptyline—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.47e-05	0.000651	CcSEcCtD
Amitriptyline—Rash—Ritonavir—acquired immunodeficiency syndrome	9.39e-05	0.000646	CcSEcCtD
Amitriptyline—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.38e-05	0.000645	CcSEcCtD
Amitriptyline—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	9.35e-05	0.000644	CcSEcCtD
Amitriptyline—ADRA2A—brain—acquired immunodeficiency syndrome	9.35e-05	0.00131	CbGeAlD
Amitriptyline—Headache—Ritonavir—acquired immunodeficiency syndrome	9.33e-05	0.000642	CcSEcCtD
Amitriptyline—CYP3A4—central nervous system—acquired immunodeficiency syndrome	9.27e-05	0.0013	CbGeAlD
Amitriptyline—HRH1—lymph node—acquired immunodeficiency syndrome	9.2e-05	0.00129	CbGeAlD
Amitriptyline—CYP2E1—brain—acquired immunodeficiency syndrome	9.15e-05	0.00128	CbGeAlD
Amitriptyline—CYP2D6—central nervous system—acquired immunodeficiency syndrome	9.12e-05	0.00128	CbGeAlD
Amitriptyline—Vomiting—Saquinavir—acquired immunodeficiency syndrome	9.11e-05	0.000627	CcSEcCtD
Amitriptyline—Dizziness—Lamivudine—acquired immunodeficiency syndrome	9.04e-05	0.000622	CcSEcCtD
Amitriptyline—ADRA2A—lymph node—acquired immunodeficiency syndrome	9.04e-05	0.00126	CbGeAlD
Amitriptyline—Rash—Saquinavir—acquired immunodeficiency syndrome	9.03e-05	0.000622	CcSEcCtD
Amitriptyline—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	9.03e-05	0.000621	CcSEcCtD
Amitriptyline—Headache—Saquinavir—acquired immunodeficiency syndrome	8.98e-05	0.000618	CcSEcCtD
Amitriptyline—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	8.92e-05	0.00125	CbGeAlD
Amitriptyline—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.84e-05	0.000609	CcSEcCtD
Amitriptyline—ABCB1—digestive system—acquired immunodeficiency syndrome	8.81e-05	0.00123	CbGeAlD
Amitriptyline—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.69e-05	0.000598	CcSEcCtD
Amitriptyline—Rash—Lamivudine—acquired immunodeficiency syndrome	8.62e-05	0.000593	CcSEcCtD
Amitriptyline—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.61e-05	0.000593	CcSEcCtD
Amitriptyline—Headache—Lamivudine—acquired immunodeficiency syndrome	8.56e-05	0.000589	CcSEcCtD
Amitriptyline—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.51e-05	0.000586	CcSEcCtD
Amitriptyline—ABCB1—blood—acquired immunodeficiency syndrome	8.4e-05	0.00117	CbGeAlD
Amitriptyline—ABCB1—bone marrow—acquired immunodeficiency syndrome	8.13e-05	0.00114	CbGeAlD
Amitriptyline—Nausea—Lamivudine—acquired immunodeficiency syndrome	8.12e-05	0.000559	CcSEcCtD
Amitriptyline—ABCB1—spinal cord—acquired immunodeficiency syndrome	8.09e-05	0.00113	CbGeAlD
Amitriptyline—HTR2A—brain—acquired immunodeficiency syndrome	7.95e-05	0.00111	CbGeAlD
Amitriptyline—ABCB1—vagina—acquired immunodeficiency syndrome	7.78e-05	0.00109	CbGeAlD
Amitriptyline—ABCB1—lung—acquired immunodeficiency syndrome	7.36e-05	0.00103	CbGeAlD
Amitriptyline—CYP2D6—brain—acquired immunodeficiency syndrome	7.24e-05	0.00101	CbGeAlD
Amitriptyline—ABCB1—nervous system—acquired immunodeficiency syndrome	6.82e-05	0.000953	CbGeAlD
Amitriptyline—ABCB1—central nervous system—acquired immunodeficiency syndrome	6.56e-05	0.000918	CbGeAlD
Amitriptyline—ABCB1—brain—acquired immunodeficiency syndrome	5.21e-05	0.000729	CbGeAlD
Amitriptyline—ABCB1—lymph node—acquired immunodeficiency syndrome	5.03e-05	0.000704	CbGeAlD
Amitriptyline—Oxcarbazepine—ALB—acquired immunodeficiency syndrome	3.33e-05	0.349	CrCbGaD
Amitriptyline—Thiothixene—ALB—acquired immunodeficiency syndrome	2.42e-05	0.254	CrCbGaD
Amitriptyline—Clomipramine—ALB—acquired immunodeficiency syndrome	1.91e-05	0.201	CrCbGaD
Amitriptyline—Nortriptyline—ALB—acquired immunodeficiency syndrome	1.87e-05	0.196	CrCbGaD
Amitriptyline—OPRK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.4e-06	0.00015	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.31e-06	0.000149	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.27e-06	0.000148	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.26e-06	0.000148	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.26e-06	0.000148	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.2e-06	0.000147	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.18e-06	0.000147	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.16e-06	0.000146	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.14e-06	0.000146	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.13e-06	0.000146	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.13e-06	0.000146	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	9.13e-06	0.000146	CbGpPWpGaD
Amitriptyline—OPRK1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.12e-06	0.000146	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.12e-06	0.000146	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.11e-06	0.000146	CbGpPWpGaD
Amitriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	9.09e-06	0.000145	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.08e-06	0.000145	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.06e-06	0.000145	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.05e-06	0.000145	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.04e-06	0.000144	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.02e-06	0.000144	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.02e-06	0.000144	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.02e-06	0.000144	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9e-06	0.000144	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.99e-06	0.000144	CbGpPWpGaD
Amitriptyline—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.99e-06	0.000144	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.99e-06	0.000144	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.99e-06	0.000144	CbGpPWpGaD
Amitriptyline—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.98e-06	0.000143	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.97e-06	0.000143	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.97e-06	0.000143	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.97e-06	0.000143	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.96e-06	0.000143	CbGpPWpGaD
Amitriptyline—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.92e-06	0.000143	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.87e-06	0.000142	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.87e-06	0.000142	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.85e-06	0.000141	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.74e-06	0.00014	CbGpPWpGaD
Amitriptyline—HTR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.74e-06	0.00014	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.61e-06	0.000138	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	8.6e-06	0.000137	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.59e-06	0.000137	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.59e-06	0.000137	CbGpPWpGaD
Amitriptyline—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.48e-06	0.000136	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.47e-06	0.000135	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.42e-06	0.000135	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.37e-06	0.000134	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.35e-06	0.000133	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.34e-06	0.000133	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.33e-06	0.000133	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.28e-06	0.000132	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.28e-06	0.000132	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.28e-06	0.000132	CbGpPWpGaD
Amitriptyline—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	8.28e-06	0.000132	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.27e-06	0.000132	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.25e-06	0.000132	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.24e-06	0.000132	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.22e-06	0.000131	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.21e-06	0.000131	CbGpPWpGaD
Amitriptyline—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.16e-06	0.00013	CbGpPWpGaD
Amitriptyline—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.16e-06	0.00013	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.13e-06	0.00013	CbGpPWpGaD
Amitriptyline—CHRM5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.12e-06	0.00013	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.11e-06	0.00013	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.11e-06	0.00013	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.11e-06	0.00013	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.1e-06	0.000129	CbGpPWpGaD
Amitriptyline—HRH4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.07e-06	0.000129	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.95e-06	0.000127	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.93e-06	0.000127	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.92e-06	0.000126	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.92e-06	0.000126	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.87e-06	0.000126	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.87e-06	0.000126	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.87e-06	0.000126	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.83e-06	0.000125	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.79e-06	0.000124	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.79e-06	0.000124	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.77e-06	0.000124	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.77e-06	0.000124	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.75e-06	0.000124	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.75e-06	0.000124	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.75e-06	0.000124	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.75e-06	0.000124	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.72e-06	0.000123	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.72e-06	0.000123	CbGpPWpGaD
Amitriptyline—OPRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.71e-06	0.000123	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.7e-06	0.000123	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.65e-06	0.000122	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.65e-06	0.000122	CbGpPWpGaD
Amitriptyline—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.64e-06	0.000122	CbGpPWpGaD
Amitriptyline—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.64e-06	0.000122	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.63e-06	0.000122	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.63e-06	0.000122	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.54e-06	0.00012	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.54e-06	0.00012	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.39e-06	0.000118	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.38e-06	0.000118	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.38e-06	0.000118	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.16e-06	0.000114	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.09e-06	0.000113	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.09e-06	0.000113	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.09e-06	0.000113	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.09e-06	0.000113	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7e-06	0.000112	CbGpPWpGaD
Amitriptyline—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.93e-06	0.000111	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.93e-06	0.000111	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.86e-06	0.00011	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.82e-06	0.000109	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.76e-06	0.000108	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.72e-06	0.000107	CbGpPWpGaD
Amitriptyline—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.66e-06	0.000106	CbGpPWpGaD
Amitriptyline—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.62e-06	0.000106	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.58e-06	0.000105	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	6.53e-06	0.000104	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.53e-06	0.000104	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.43e-06	0.000103	CbGpPWpGaD
Amitriptyline—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.34e-06	0.000101	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.29e-06	0.0001	CbGpPWpGaD
Amitriptyline—HRH2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.26e-06	0.0001	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.18e-06	9.87e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.15e-06	9.82e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.11e-06	9.76e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.04e-06	9.66e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.02e-06	9.62e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.01e-06	9.61e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6e-06	9.59e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.93e-06	9.48e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.93e-06	9.47e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.91e-06	9.45e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.89e-06	9.42e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.88e-06	9.4e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.87e-06	9.39e-05	CbGpPWpGaD
Amitriptyline—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.84e-06	9.34e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.84e-06	9.32e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.82e-06	9.3e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.82e-06	9.3e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.81e-06	9.28e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.8e-06	9.27e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.79e-06	9.25e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.76e-06	9.2e-05	CbGpPWpGaD
Amitriptyline—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.75e-06	9.19e-05	CbGpPWpGaD
Amitriptyline—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.74e-06	9.17e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.73e-06	9.16e-05	CbGpPWpGaD
Amitriptyline—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.72e-06	9.14e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.72e-06	9.13e-05	CbGpPWpGaD
Amitriptyline—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.7e-06	9.11e-05	CbGpPWpGaD
Amitriptyline—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.65e-06	9.02e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.63e-06	8.99e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.58e-06	8.92e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.55e-06	8.87e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.43e-06	8.67e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.39e-06	8.61e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.34e-06	8.53e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.33e-06	8.51e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.31e-06	8.48e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.31e-06	8.48e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.31e-06	8.48e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.29e-06	8.46e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.24e-06	8.37e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.23e-06	8.36e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.23e-06	8.35e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.22e-06	8.34e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.21e-06	8.32e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.19e-06	8.3e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.18e-06	8.27e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	5.13e-06	8.2e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.13e-06	8.19e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.11e-06	8.17e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.89e-06	7.82e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.87e-06	7.78e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.86e-06	7.76e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.82e-06	7.71e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.82e-06	7.7e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.8e-06	7.67e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.79e-06	7.66e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.79e-06	7.65e-05	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.77e-06	7.62e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.76e-06	7.61e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.75e-06	7.59e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.69e-06	7.49e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.66e-06	7.45e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.55e-06	7.27e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.53e-06	7.23e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	4.51e-06	7.21e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.36e-06	6.96e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.34e-06	6.94e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.34e-06	6.93e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	4.14e-06	6.61e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.14e-06	6.61e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.12e-06	6.58e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.1e-06	6.54e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.1e-06	6.54e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.08e-06	6.51e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.08e-06	6.51e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—ALB—acquired immunodeficiency syndrome	3.88e-06	6.2e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	3.8e-06	6.07e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	3.79e-06	6.06e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.7e-06	5.91e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.57e-06	5.7e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.55e-06	5.68e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.55e-06	5.67e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.53e-06	5.65e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.4e-06	5.43e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.38e-06	5.41e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	3.28e-06	5.25e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.28e-06	5.24e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.13e-06	5.01e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.12e-06	4.98e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.08e-06	4.93e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.08e-06	4.92e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.07e-06	4.9e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.07e-06	4.9e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.06e-06	4.89e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.06e-06	4.89e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.05e-06	4.88e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.04e-06	4.86e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.03e-06	4.84e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.02e-06	4.83e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.01e-06	4.81e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.01e-06	4.8e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	2.93e-06	4.68e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.88e-06	4.6e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	2.86e-06	4.57e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.84e-06	4.53e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.83e-06	4.52e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.81e-06	4.49e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.81e-06	4.48e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.79e-06	4.46e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.75e-06	4.4e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	2.7e-06	4.31e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.67e-06	4.27e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	2.67e-06	4.27e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.56e-06	4.09e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.43e-06	3.88e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.41e-06	3.85e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.41e-06	3.85e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	2.28e-06	3.65e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.1e-06	3.35e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.09e-06	3.34e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2e-06	3.19e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.84e-06	2.94e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.81e-06	2.9e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.81e-06	2.89e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.8e-06	2.88e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.8e-06	2.87e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.78e-06	2.84e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.78e-06	2.84e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	1.76e-06	2.82e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.65e-06	2.64e-05	CbGpPWpGaD
